-- Telix Pharmaceuticals（ASX：TLX）週二表示，其在開發顯影劑TLX250-Px有望用於診斷除透明細胞腎細胞癌（ccRCC）以外的其他腎癌。該公司援引發表在《歐洲泌尿外科雜誌》（European Urology）上的一項獨立分析稱，該分析顯示，TLX250-Px的三期臨床試驗數據表明，PET掃描陽性結果對惡性腫瘤具有“高度預測性”，包括非透明細胞腎細胞癌，其陽性預測值高達98%。 Telix集團首席醫療官David Cade表示：“ZIRCON研究中幾乎所有ccRCC假陽性結果均已被證實為其他惡性腎癌亞型，這降低了過度治療的風險，並進一步支持了該藥物的臨床應用。”
Related Articles
Asia
Market Chatter: Billionaire Pamela Wall Said to Sell AU$300 Million Codan Shares in Block Trade
Codan's (ASX:CDA) largest individual shareholder, the billionaire Pamela Wall, is said to have approved a block trade, valued at around AU$300 million, the Australian Financial Review reported Tuesday, citing anonymous people involved in the transaction.Wall will retain around AU$1.2 billion in Codan shares after the reported sell down.Canaccord Genuity is said to be working on the trade. It is understood shares were being offered at about AU$39 each, per the report.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
$ASX:CDA
Asia
Great Boulder Resources Secures AU$40 Million in Two-Tranche Placement; Shares Up 19%
Great Boulder Resources (ASX:GBR) secured firm commitments to raise AU$40 million from institutional and sophisticated investors through a two-tranche placement, issuing around 470.6 million shares at AU$0.085 each, representing a discount of nearly 14% to its 10-day volume-weighted average price, according to a Tuesday filing with the Australian bourse.The first tranche is expected to raise about AU$12.4 million from 145.5 million shares, while the second tranche aims to generate around AU$27.6 million from 325.1 million shares, subject to shareholder approval, the filing said.The funds will be used to support the company's acquisition of the Peak Hill gold project from Aragon Resources, a wholly owned subsidiary of Westgold Resources (ASX:WGX), the filing added.The company's shares jumped 19% in recent Tuesday trade.
$ASX:GBR$ASX:WGX
Asia
Grab Attributable Profit Surges in Q1
Singapore-headquartered ride-hailing company Grab reported attributable profit of $136 million in the first quarter of the year from $24 million a year earlier, according to a company release on Tuesday.Basic earnings per share were $0.03 compared with EPS of $0.01 a year ago.Revenue climbed 24% year over year to $955 million from $773 million, backed by growth across the on-demand and financial services segments.
$^STI